1. Home
  2. LIXT vs OLB Comparison

LIXT vs OLB Comparison

Compare LIXT & OLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • OLB
  • Stock Information
  • Founded
  • LIXT 2005
  • OLB 1993
  • Country
  • LIXT United States
  • OLB United States
  • Employees
  • LIXT N/A
  • OLB N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • OLB EDP Services
  • Sector
  • LIXT Health Care
  • OLB Technology
  • Exchange
  • LIXT Nasdaq
  • OLB Nasdaq
  • Market Cap
  • LIXT 4.2M
  • OLB 4.0M
  • IPO Year
  • LIXT N/A
  • OLB N/A
  • Fundamental
  • Price
  • LIXT $1.62
  • OLB $1.89
  • Analyst Decision
  • LIXT
  • OLB
  • Analyst Count
  • LIXT 0
  • OLB 0
  • Target Price
  • LIXT N/A
  • OLB N/A
  • AVG Volume (30 Days)
  • LIXT 1.8M
  • OLB 149.7K
  • Earning Date
  • LIXT 11-12-2024
  • OLB 11-15-2024
  • Dividend Yield
  • LIXT N/A
  • OLB N/A
  • EPS Growth
  • LIXT N/A
  • OLB N/A
  • EPS
  • LIXT N/A
  • OLB N/A
  • Revenue
  • LIXT N/A
  • OLB $16,011,854.00
  • Revenue This Year
  • LIXT N/A
  • OLB N/A
  • Revenue Next Year
  • LIXT N/A
  • OLB N/A
  • P/E Ratio
  • LIXT N/A
  • OLB N/A
  • Revenue Growth
  • LIXT N/A
  • OLB N/A
  • 52 Week Low
  • LIXT $1.31
  • OLB $1.64
  • 52 Week High
  • LIXT $4.42
  • OLB $11.70
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 43.04
  • OLB 43.95
  • Support Level
  • LIXT $1.56
  • OLB $1.79
  • Resistance Level
  • LIXT $1.87
  • OLB $2.70
  • Average True Range (ATR)
  • LIXT 0.23
  • OLB 0.33
  • MACD
  • LIXT -0.03
  • OLB -0.00
  • Stochastic Oscillator
  • LIXT 8.33
  • OLB 22.12

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The Company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.

Share on Social Networks: